Vikram Khurana
Affiliations: | Whitehead Institute, Cambridge, MA, United States |
Area:
Neurodegeneration (Drosophila, Yeast, Stem Cell)Google:
"Vikram Khurana"Mean distance: 15.2 (cluster 31) | S | N | B | C | P |
Cross-listing: FlyTree
Parents
Sign in to add mentor| Mel B. Feany | grad student | 2006 | Harvard | |
| (Mitogenic signaling and cell-cycle activation mediate neurodegeneration in Drosophila.) | ||||
| Rudolf Jaenisch | post-doc | Whitehead Institute | ||
| Susan L. Lindquist | post-doc | Whitehead Institute (FlyTree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Santhosh Kumar S, Naseri NN, Pather SR, et al. (2024) Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science Advances. 10: eadj4767 |
| Maltby CJ, Krans A, Grudzien SJ, et al. (2023) AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS Neurons. Biorxiv : the Preprint Server For Biology |
| Ndayisaba A, Pitaro AT, Willett AS, et al. (2022) Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping. Cerebellum (London, England) |
| Raja WK, Neves E, Burke C, et al. (2022) Patient-derived three-dimensional cortical neurospheres to model Parkinson's disease. Plos One. 17: e0277532 |
| Ndayisaba A, Pitaro AT, Willett AS, et al. (2022) Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping. Cerebellum (London, England) |
| Kim J, Young GS, Willett AS, et al. (2022) Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects. Cerebellum (London, England) |
| Hallacli E, Kayatekin C, Nazeen S, et al. (2022) The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 185: 2035-2056.e33 |
| Carmona-Abellan M, Gabilondo I, Murueta-Goyena A, et al. (2019) Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers. Parkinsonism & Related Disorders |
| Lam I, Hallacli E, Khurana V. (2019) Proteome-Scale Mapping of Perturbed Proteostasis in Living Cells. Cold Spring Harbor Perspectives in Biology |
| Sanz R, Ovando-Roche P, Udeshi ND, et al. (2019) In Situ Peroxidase Labeling and Mass Spectrometry of Alpha-Synuclein in Rat Cortical Neurons. Methods in Molecular Biology (Clifton, N.J.). 1948: 235-246 |